structure and pharmacological action of the drug "Trimedat»



One tablet contains 100 mg or 200 mg of active substance - trimebutine maleate.Also in the "Trimedata" includes the following auxiliary ingredients: lactose, corn starch, silicon dioxide, magnesium stearate and talc.

«Trimedat" leads to normal physiological activity of the muscles of the intestines, impaired as a result of diseases of the gastrointestinal tract: stimulates muscle contractions of the intestine with reduced activity and relaxes the muscles in the over-activity of the intestine.

Indications, contraindications and side effects



«Trimedat" can be administered in th
e treatment of the following diseases and conditions:

- irritable bowel syndrome (pain, colic, intestinal cramps, diarrhea, constipation and flatulence);

- gastroesophageal reflux disease;

- dyspeptic disorders (dyspepsia, abdominal pain, nausea, vomiting);

- paralytic ileus, which developed as a result of surgery.

In addition, "Trimedat" is used in preparation for X-ray examination or endoscopy of the stomach.Also, the drug can be used in the treatment of dyspeptic disorders in children.

«Trimedat" does not apply in case of hypersensitivity to its member components and is not indicated for children younger than 3 years.The use of "Trimedata" is not recommended in the I trimester of pregnancy and breastfeeding.Side effects of the drug may manifest as skin reactions, but they occur in rare cases.

Dosing and Administration



tablets should be taken orally 3 times a day.Recommended instructions to "Trimedatu" single dose for adults and children over 12 years old is 100-200 mg.The maximum dose of the drug (600 mg daily) is administered in the treatment of the acute stage of the disease.Children aged 5 to 12 years: 50 mg single dose, while children 3 to 5 years - 25 mg.

duration of treatment is determined by the attending physician.In the treatment of irritable bowel syndrome the recommended duration of dosing is 4 weeks.After completion of treatment is usually given prophylactic "Trimedata" for 12 weeks, which avoids relapse.